Fairvalue-Calculator Fairvalue-Calculator
EN DE

PT Lippo Karawaci Tbk (LPKR) Fair Value & Analysis

Healthcare · ID · Market cap 4.2T IDR

Price58.00 IDR
Fair Value112.62 IDR
Upside+94.2%
Quality92/100
Evidence: High Range 84.46 IDR – 140.77 IDR

Fair value as of: Jun 26, 2026

Analysis

PT Lippo Karawaci Tbk (LPKR) currently trades at 58.00 IDR, while our model-based Fair Value estimate is 112.62 IDR — implying the stock looks roughly 94.2% undervalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

PT Lippo Karawaci Tbk engages in real estate development, healthcare and lifestyle businesses in Indonesia. The company is also involved in investment, development, trading, home care, and financing activities; installation and water treatment; town management; urban development; marketing and building management; clean water and waste management; hotel management; catering service; and provision of accommodation and burial services. PT Lippo Karawaci Tbk founded in 1990 and is based in Tangerang, Indonesia.

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) -74% Fresenius SE (FSNUY) -24% 5225 (5225) -39% IHHHF (IHHHF) -57% Rede D'Or São Luiz S.A (RDOR3) +42% Tenet Healthcare Corporation (THC) +70%

Frequently asked questions

Is PT Lippo Karawaci Tbk (LPKR) undervalued?
As of Jun 26, 2026, our model estimates a fair value of 112.62 IDR versus a price of 58.00 IDR — about +94% (undervalued). Model-based estimate, not financial advice.
What is the fair value of LPKR?
Our 21-model fair value for PT Lippo Karawaci Tbk is 112.62 IDR (as of Jun 26, 2026), built from audited fundamentals. The current price is 58.00 IDR.
What is the quality score of LPKR?
PT Lippo Karawaci Tbk has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.